Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX

Knight Jeff E. sold 85,163 Crinetics Pharmaceuticals, Inc. shares (Form 4)

Traded Apr 8, 2026 · Filed Apr 10, 2026

On Apr 8, 2026, Knight Jeff E. (Chief Dev. & Operating Officer) sold 85,163 Crinetics Pharmaceuticals, Inc. shares at US$40.10 for US$3.42M under a trading plan, leaving 105,289 shares. Filed Apr 10, 2026 (Form 4).

Sold
85,163 shares
Price
US$40.10
Value
US$3.42M
Holding after
105,289 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Dev. & Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 8, 2026Common StockOption exercise49,474US$23.98161,492Direct
Apr 8, 2026Common StockOption exercise9,624US$20.02171,116Direct
Apr 8, 2026Common StockOption exercise19,336US$19.64190,452Direct
Apr 8, 2026Common StockSale85,163US$40.10105,289Direct

Source

View original at SEC

Related